Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system

BackgroundLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease. The induction of LABD by medications is a critical issue, with previous studies highlighting the link between specific drugs and the onset of LABD. This study aims to assess the reported associations between LABD...

Full description

Saved in:
Bibliographic Details
Main Authors: Yixuan Yang, Hanzhang Xie, Shuhan Liu, Ying Jia, Bingnan Cui, Zhanshuo Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
linear IgA bullous dermatosis
drug-induced linear IgA bullous dermatosis
adverse event
FAERS
pharmacovigilance study
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1521697/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items